Clinical Guidelines and Quality Standards Documents
ASNC is committed to documenting and providing evidence-based standards for the field of nuclear cardiology and cardiovascular CT. ASNC served as the author or co-author on each of the clinical guidelines and position statements listed below. The date shown with each guideline or statement reflects the most recent date of approval or endorsement. Clinical guidelines that pertain to our educational activities are also listed below.
Clinical documents related to nuclear cardiology training (such as COCATS)  |
NEW! PET REPORTING TEMPLATE Atlas for Reporting PET Myocardial Perfusion Imaging and Myocardial Blood Flow in Clinical Practice |
(1).PNG){kind=spacer} |
NEW! AMYLOID REPORTING TEMPLATE Interpretation and Reporting of Cardiac Scintigraphy with Bone-avid Tracers in Suspected Transthyretin Cardiac Amyloidosis |
 |
QUALITY METRICS INFORMATION STATEMENT |
 |
HYBRID IMAGING GUIDELINE ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging |
READ NOW– Visit our new Journal of Nuclear Cardiology (JNC) website to access the full text guidelines while we are in the process of updating the links on this page. Members please log in to gain full access to the JNC site. (The link can be found on the left side navigation bar.)
Imaging Guidelines for Nuclear Cardiology Procedures
Relevant protocols developed through evidence- or consensus-based standards for the field of Nuclear Cardiology. Introduction
- Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation- 2018
- Standardized Reporting of Nuclear Cardiology Procedures - 2017
- SPECT: Stress, Protocols, and Tracers - 2016
- SPECT: Stress, Protocols, and Tracers - 2016 - Chinese Edition (Translated in 2017)
- Single Photon Emission Computed Tomography - 2010- Chinese Edition (Translated in 2016)
- Single Photon Emission Computed Tomography - 2010 - Spanish Edition (Translated in 2014)
Appropriate Use Criteria
Statements that denote when it is appropriate to perform a medical service or procedure, with the expectation that the benefits of such a service or procedure significantly outweigh the potential risks
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease - 2017
- ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease - 2017
- Appropriate Use for Diagnostic Catheterization - 2012
- Appropriate Use Criteria for Coronary Revascularization: Focused update - 2012
- Appropriate Use Criteria for Echocardiography - 2010
- Evaluating Appropriateness for Cardiac Computed Tomography - 2011 (Summary)
- Appropriate Use Criteria for Cardiac Computed Tomography - 2010
- Appropriate Use Criteria for Cardiac Radionuclide Imaging - 2009
Appendix: Appropriate Use Criteria for Cardiac Radionuclide Imaging Data Supplement - 2009 - Appropriate Use Criteria for Stress Echocardiography - 2008
- Appropriate Use Criteria for Transthoracic and Transesophageal Echocardiography - 2007
- Appropriate Use Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging - 2006
Preferred Practice Statements
A set of predominantly forward-looking statements focusing on the goals of Nuclear Cardiology Imaging
- Patient-Centered Imaging - 2012
Information Statements
Educational tools comprised of systematic reviews of clinical concepts and scientific evidence that serve as a resource to advise clinicians
- Update on Guidance and Best Practices for Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: Emphasis on Transition to Chronic Endemic State - 2022
- Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow - 2021
- Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI - 2020
- Guidance and Best Practices for Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC and SNMMI - 2020
- Aminophylline shortage and current recommendations for reversal of vasodilator stress - 2018
- Contemporary Cardiac SPECT Imaging - Innovations and Best Practices - 2018
- Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task
Force - 2017 - Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease— state-of-the-evidence and clinical recommendations - 2017
- The Role of Clinical Effectiveness of Multimodality Imaging in the Management of Cardiac Complications of Cancer and Cancer Therapy - 2016
- ASNC Model Coverage Policy: Cardiac Positron Emission Tomographic Imaging - 2014
- Strategies for Defining an Optimal Risk-Benefit Ratio for Stress Myocardial Perfusion SPECT - 2011
- The Role of Radionuclide Myocardial Perfusion Imaging for Asymptomatic Individuals - 2011
- Recommendations for Reducing Exposure in Myocardial Perfusion Imaging - 2010
- Variability in Radiation Dose Estimates from Nuclear and Computed Tomography Diagnostic Imaging - 2009
- DICOM and Interconnectivity Update - 2009
- ASNC Review of the ACCF/ASNC Appropriateness Criteria for SPECT MPI - 2007
- Cost-Effectiveness of Myocardial Perfusion Imaging - 2005
Position Statements
A set of statements that serve as an expression of ASNC’s stance on specific practice, policy, or professional issues
- American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET - 2016
- The Role of Radiology Benefits Managers and Private Insurers in the Physician-Patient Relationship: A Statement in Opposition of Test Substitution - 2011
Other ASNC Documents
Other Clinical Guidelines
- COVID-19 pandemic: guidance for nuclear medicine departments - International Atomic Energy Agency (IAEA) 2020
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - ACCF/AHA Guideline - 2011
- Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertropic Cardiomyopathy - ASE Guidelines - 2011
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2011 Update - AHA Guideline - 2011
- 2010 ACCF/AHA Guidelines for Assessment of Cardiovascular Risk in Asymptomatic Adults - 2010
(Click here for the Executive Summary) - Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung and Blood Institute - 2009
- ASNC Imaging Guidelines on New Technology for Clinical Use - 2009
- ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery - 2009
Joint Society Statements
Public statements on issues within the field of Cardiology that are supported by multiple professional societies and experts
- Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging - 2021
- Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow - 2021
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations For Multimodality Imaging in Cardiac Amyloidosis - 2019
Part 1 of 2—Evidence base and standardized methods of imaging
Part 2 of 2—Diagnostic criteria and appropriate utilization - Clinical quantification of myocardial blood flow using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC - 2017
- A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology - 2017
- Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring - 2017
- ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures - 2016
- ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise - 2016
- TF 7 Cardiovascular Computed Tomographic Imaging - 2015
- TF 6 Nuclear Cardiology - 2015
- Approaches to Enhancing Radiation Safety in Cardiovascular Imaging: A Scientific Statement From the American Heart Association - 2014
- SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0* - 2013
- ACCF/AHA Focused Update on Perioperative Beta Blockade - 2009
- Key Data Elements and Definitions for Cardiac Imaging - 2008
- Health Policy Statement on Structured Reporting in Cardiovascular Imaging - 2008
Archived Documents
- ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine~123 meta-iodobenzylguanidine (123I~mIBG) - 2015
- Developing an Action Plan for Patient Radiation Safety in Adult Cardiovascular Medicine - 2012
- Single Photon Emission Computed Tomography - 2010
- Stress Protocols and Tracers - 2009
- Conference Proceedings from the 9th Nuclear Cardiology Invitational Conference - 2008
- Clinical Competence Statement on Cardiac Imaging with Computed Tomography and Magnetic Resonance - 2005
- (Click here for the correction posted online November 23, 2009)
- A Report of the ASNC Task Force on Women and Heart Disease - 2003
- A Suspected Acute Ischemic Syndromes in the Emergency Department or Chest Pain Center - 2002
ASNC Disclosure of Conflicts of Interest (COI) With Industry and Other Entities
Appendix A Chart: ASNC Risk Assessment & Automatic COI Resolutions
Appendix A Chart: ASNC Risk Assessment & Automatic COI Resolutions